WHO: Weight Loss Drugs New Obesity Chapter
The World Health Organization has officially recognized GLP-1 weight loss medications, including Mounjaro and Wegovy, as a significant breakthrough in combating the escalating global obesity crisis, marking a pivotal shift in how the international health body views treatment. Amidst projections that global obesity will affect two billion people by 2030, the WHO is now urging countries to enhance access to these therapies and calling on pharmaceutical companies to lower prices and increase production to ensure equitable availability worldwide.